Knowingly, inflammation plays critical and continuous roles on the initiation and progression of atherosclerosis and ASCVD [2,3], and increased serum level of inflammatory biomarker such as high sensitivity C-reactive protein (Hs-CRP) has been recognized as an important predictor for cardiovascular diseases risk [4,5]. This evidence concerns the gene CRP and atherosclerosis.